Live Breaking News & Updates on Recipharmb share

Stay informed with the latest breaking news from Recipharmb share on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Recipharmb share and stay connected to the pulse of your community

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications
Monday, 01 February 2021 18:00
Hits: 6982

ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / --Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce that they have now completed the previously announced joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the mouth and throat.

Germany , India , Stockholm , Sweden , Munich , Bayern , Netherlands , United-kingdom , Israel , Enschede , Overijssel , Italy

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmace

Recipharm and Medspray Launch Resyca Joint Venture to Exploit Novel Softmist Technology for Pharmaceutical Applications

ENSCHEDE, the Netherlands, February 01, 2021 / B3C newswire / --Recipharm AB (publ) (“Recipharm”), a leading contract development and manufacturing organisation (CDMO) and Medspray BV (“Medspray”), a manufacturer of high tech spray nozzles, announce that they have now completed the previously announced joint venture and established Resyca BV. Resyca will develop and exploit the softmist spray nozzle technology for pharmaceutical applications. This has the potential to eliminate the need for propellants by delivering therapies deep into the lungs more effectively with lower doses as less ends up in the mouth and throat.

Germany , India , Stockholm , Sweden , Munich , Bayern , Netherlands , United-kingdom , Israel , Enschede , Overijssel , Italy

Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S. - Press Release

Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S. - Press Release
digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.

Germany , India , Stockholm , Sweden , United-kingdom , Israel , Italy , Portugal , Cambridge , Cambridgeshire , France , Spain

Moderna, Inc.: Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S.

(2)
Moderna, Inc. (NASDAQ:MRNA), biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Recipharm (STO: RECI-B), a leading contract development and manufacturing organization (CDMO), today announced that they have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 Vaccine supply outside of the U.S. The activity will be performed in Recipharm's drug product manufacturing facility located in France.
Subject to regulatory approval of the vaccine in relevant countries outside of the U.S., it is anticipated that supply will commence in early 2021.
"We are making important progress in the development of the Moderna COVID-19 Vaccine and we are pleased to be entering into this collaboration with Recipharm," said Nicolas Chornet, Senior Vice President, International Manufacturing of Moderna. "We look forward to their support in the delivery of our vaccine to market."

Germany , India , Stockholm , Sweden , United-kingdom , Israel , Italy , Portugal , Cambridge , Cambridgeshire , France , Spain

Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S.

Recipharm and Moderna Finalize Agreement for Aseptic Drug Product Manufacturing and Fill-Finish for Supply to Countries Outside the U.S.
marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.

Germany , India , Stockholm , Sweden , United-kingdom , Israel , Italy , Portugal , Cambridge , Cambridgeshire , France , Spain